YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism

Phase 1

Completed

Conditions: Schizophrenia

Interventions: Drug: ketamine

First Posted Date: 2016-02-05

Last Posted Date: 2016-02-05

Lead Sponsor: Yale University

Target Recruit Count: 33

Registration Number: NCT02675530

Locations: 🇺🇸
VHA CT, West Haven, Connecticut, United States

Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Other: basal interruption without canagliflozin
Drug: canagliflozin

First Posted Date: 2016-02-03

Last Posted Date: 2021-10-13

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT02673138

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects

Not Applicable

Completed

Conditions: Diabetes

Interventions: Device: Continuous Glucose Monitoring System (CGMS)
Behavioral: Food log

First Posted Date: 2016-02-03

Last Posted Date: 2022-05-05

Lead Sponsor: Yale University

Target Recruit Count: 31

Registration Number: NCT02673203

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

A Sunscreen Based on Bioadhesive Nanoparticles

Phase 1

Completed

Conditions: Melanoma
UV Ray Skin Damage

Interventions: Drug: Standard Sunscreen
Device: BNP

First Posted Date: 2016-01-29

Last Posted Date: 2018-03-13

Lead Sponsor: Yale University

Target Recruit Count: 13

Registration Number: NCT02668536

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia

Phase 2

Completed

Conditions: Relapsed/Refractory Acute Myeloid Leukemia

Interventions: Drug: Nintedanib and AML induction

First Posted Date: 2016-01-27

Last Posted Date: 2022-04-08

Lead Sponsor: Yale University

Target Recruit Count: 25

Registration Number: NCT02665143

Locations: 🇺🇸
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

Insomnia Self-Management in Heart Failure

Not Applicable

Completed

Conditions: Fatigue
Sleep Initiation and Maintenance Disorders
Pain
Chronic Insomnia
Cardiac Failure
Heart Failure
Heart Failure, Congestive
Disorders of Initiating and Maintaining Sleep
Anxiety
Congestive Heart Failure

Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia
Behavioral: Self-Management Education for Heart Failure

First Posted Date: 2016-01-21

Last Posted Date: 2023-02-09

Lead Sponsor: Yale University

Target Recruit Count: 195

Registration Number: NCT02660385

Locations: 🇺🇸
Yale University School of Nursing, West Haven, Connecticut, United States

Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)

Not Applicable

Completed

Conditions: Smoking Cessation
Biofeedback

Interventions: Behavioral: personalized cessation care
Behavioral: bio feedback
Other: standard care

First Posted Date: 2016-01-18

Last Posted Date: 2023-04-21

Lead Sponsor: Yale University

Target Recruit Count: 276

Registration Number: NCT02658032

Locations: 🇺🇸
Medical University of South Carolina: Hollings Cancer Center, Charleston, South Carolina, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis

Terminated

Conditions: Ichthyosis

Interventions: Other: Observation

First Posted Date: 2016-01-14

Last Posted Date: 2020-07-07

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT02655861

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome

Phase 1

Completed

Conditions: Obesity

First Posted Date: 2016-01-14

Last Posted Date: 2018-05-11

Lead Sponsor: Yale University

Target Recruit Count: 22

Registration Number: NCT02656056

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Prevention of Delirium in Inpatients Utilizing Melatonin

Phase 3

Terminated

Conditions: Delirium

Interventions: Other: Placebo
Drug: Melatonin

First Posted Date: 2016-01-13

Last Posted Date: 2022-03-21

Lead Sponsor: Yale University

Target Recruit Count: 277

Registration Number: NCT02654314

Locations: 🇺🇸
Yale New Haven Hospital, Saint Raphael Campus, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy